Light Therapy Market

Increased incidence of conditions including depression and Insomnia will accelerate market expansion of light therapy

Depression is a common illness worldwide, impacting more than 264 million people as of 2020, according to a report published by the World Health Organization. Since 2016, mental and addictive disorders impacted over a billion people, comprising 7% of all  burden of disease as measured in disability-adjusted life years (DALYs).Also, according to the US National Institute of Mental Health (NIMH), around 52 million adults, or one in five of all people, suffered from mental illnesses as of 2019.

As people increasingly lead sedentary lifestyles, sleep disorder incidences are experiencing a significant incline. The American Sleep Association forecasts that 50-70 million US adults have a sleep disorder, with chronic insomnia accounting for a tenth of overall sleep disorders. Furthermore, 37% of 20-39-year-olds report short sleep duration, while 40% of them belong to the 40-59-year-old category. ly, insomnia incidences amount to 10-30% of the  population, sometimes reaching as high as 50-60%. The consequences of insomnia are significant, such as depression, impaired work performance, work-related or motor vehicle accidents, and overall poor quality of life.

Fortunately, this condition is preventable with a variety of treatment alternatives available.

Light therapy is one such approach, as it is known to correct an individual’s circadian rhythm, which is a part of the body’s internal clock that causes one to feel alert and awake during the daytime and sleepy at night. When used correctly, light therapy can encourage a circadian rhythm reset which may help improve sleep outcomes.

According to a study published by the National Center for Biotechnology Information in 2013, skin conditions contributed to nearly 2% of the total  burden of disease as measured in disability-adjusted life years (DALYs). Skin and subcutaneous disorders were the 4th leading cause of non-fatal disease burden. Dermatitis resulted in the greatest burden, costing 9.3 million DALYs.The World Health Organization noted in 2016 that the reported prevalence of psoriasis worldwide ranged between 0.09% and 11.43%, making it a serious problem. In the United States, it affects about 7.4 million people.

Also, 30-33% of people with psoriasis go on to develop psoriatic arthritis, while guttate psoriasis affects 8% of the people with this condition, while plaque psoriasis comprises constitutes 80-90% of the cases. There these are the key factors which will boost market CAGR of light therapy.

The rising prevalence of sleep disorders is a notable driver for the Global Global Light Therapy Market Industry. Conditions such as insomnia and circadian rhythm disorders are becoming more common, prompting individuals to seek effective treatment options. Light therapy has been recognized as a viable solution for regulating sleep patterns and improving overall sleep quality. With the market projected to reach 1.82 USD Billion by 2035, the increasing awareness of light therapy's role in managing sleep disorders is likely to contribute significantly to market growth. This trend underscores the importance of light therapy in addressing contemporary health challenges.

The Global Global Light Therapy Market Industry is experiencing a surge in demand due to increasing awareness of the mental health benefits associated with light therapy. As more individuals seek non-invasive treatments for conditions such as Seasonal Affective Disorder (SAD) and depression, the market is projected to reach 1.03 USD Billion in 2024. This growing recognition of light therapy's efficacy is likely to drive adoption rates, particularly in regions where mental health awareness is on the rise. Additionally, healthcare providers are increasingly recommending light therapy as a complementary treatment, further bolstering its market presence.

There is a notable shift towards non-invasive treatment options in the Global Global Light Therapy Market Industry. Patients are increasingly favoring therapies that do not involve pharmaceuticals or surgical procedures, leading to a rise in the adoption of light therapy. This trend is particularly evident in the treatment of skin conditions, mood disorders, and sleep issues. As healthcare systems worldwide emphasize patient-centered care, the demand for light therapy is expected to grow, contributing to the market's expansion. The appeal of non-invasive treatments aligns with broader healthcare trends focused on holistic and preventive care.

Government initiatives and regulations play a crucial role in shaping the Global Global Light Therapy Market Industry. Many countries are implementing policies that promote mental health awareness and support alternative therapies, including light therapy. These initiatives often include funding for research and development, as well as public health campaigns aimed at educating the population about the benefits of light therapy. Such support is likely to enhance market growth, as it encourages both consumers and healthcare providers to consider light therapy as a legitimate treatment option. This regulatory environment fosters innovation and investment in the light therapy sector.

Innovations in technology are significantly influencing the Global Global Light Therapy Market Industry. The development of portable and user-friendly devices has made light therapy more accessible to consumers. For instance, advancements in LED technology have enhanced the effectiveness and efficiency of light therapy devices. These innovations not only improve treatment outcomes but also cater to the growing demand for at-home therapy solutions. As a result, the market is expected to grow at a CAGR of 5.33% from 2025 to 2035, indicating a strong potential for future expansion driven by technological progress.

By Region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America Light Therapy market accounted for USD 0.34 billion in 2021 and is expected to exhibit a significant CAGR growth during the study period. North America dominated the phototherapy equipment market with a revenue share of 43.20% in 2021. The rising number of various skin conditions such as vitiligo, psoriasis, eczema, and acne is expected to help the region dominate the phototherapy equipment market.

For instance, according to the Canadian Dermatology Association, acne affects around 5.6 million people in Canada, i.e., 20% of the total population suffers from acne. Similarly, as per the latest estimates by Atopic Dermatitis in America, around 7.3% of U.S. adults suffer from eczema, while around 40% of the people suffer from moderate to severe symptoms.

Further, the major countries studied in the market report are The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3 LIGHT THERAPY MARKET SHARE BY REGION 2023 (%)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

However, the Asia-Pacific region is projected to witness the fastest growth rate of 5.55% during the forecast period. The increase in the number of births of pre-term babies and a number of people suffering from skin disorders can be accredited to the high growth rate. For instance, as per The Lancet, around 85% of preterm births occur in the late preterm period, out of which 80% occur in Asia & South-Asian regions. Moreover, according to Narayan Health Organization, out of the 15 million pre-term births ly, 1/5th of these births take place in India alone.

Additionally, people in the Asia Pacific are prone to acne, which is further expected to propel the use of phototherapy equipment. For instance, according to the Derma Health Institute, acne is a common condition for people of Asian ethnicity, thereby impelling the phototherapy equipment market in this region.

Europe Light Therapy market accounts for the third-largest market share are due  to Growth of europe market of light therapy is majorly driven by increase in skin disorders, rise in patients suffering from depression, increase in prevalence of seasonal affective depression, and mood conditions. Moreover, increased urge to look beautiful cause rise in adoption of light therapies in the female population. Thus, this factor is anticipated to fuel the growth of market. Further, the Germany market of light therapy held the largest market share, and the UK market of light therapy was the fastest growing market in the European region

Major market players are spending a lot of money on R&D to increase their product lines, which will help in the market growth of Light Therapy. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the Light Therapy industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

One of the primary business strategies adopted by manufacturers in the  Light Therapy industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, Light Therapy industry has provided medicine with some of the most significant benefits. The Light Therapy market major player such as Beurer (Germany),  Northern Light Technology (Canada),   BioPhotas (US),   Chal-Tec GmbH (Germany),   Koninklijke Philips (Netherlands)   Lucimed SA (Belgium), Lumie (UK), Verilux (US),  Nature Bright (Taiwan),  Zepter International (Switzerland)., and others are working to expand the market demand by investing in research and development activities.

Beurer GmbH is a German family-owned Mittelstand manufacturer of electrical devices for health and well-being. Originally a manufacturer of electric blankets, the company began diversifying its product line in the 1980s and now sell some 2,200 products including weighing scales, blood pressure monitors, and mobile ECG devices.

Koninklijke Philips N.V.  commonly shortened to Philips, is Dutch multinational conglomerate corporation that was founded in Eindhoven in 1891.  Philips was formerly one of the largest electronics companies in the world, but is currently focused on the area of health technology, having divested its other divisions.